Related Experiment Videos
Early cellular events in the lung allograft
The Annals of Thoracic Surgery
|December 1, 1992
Summary
Ischemia-reperfusion injury in lung allografts increases immune cell activity and susceptibility to rejection. This early immune response, including natural killer cell activation, primes the lung for rejection within a week.
Area of Science:
- Transplantation immunology
- Pulmonary medicine
- Surgical research
Background:
- Ischemic insult is a critical factor in organ transplant outcomes.
- Understanding early post-transplant events is crucial for preventing lung allograft rejection.
Purpose of the Study:
- To investigate the impact of ischemia-reperfusion injury on lung allograft susceptibility to rejection.
- To characterize early cellular and molecular changes in canine lung allografts following transplantation.
Main Methods:
- Canine single-lung allografts underwent standard cold and warm ischemia periods.
- Bronchoalveolar lavage and lung biopsies were analyzed at multiple time points post-transplantation.
- Assessed cellular phenotypes, cytotoxicity, and MHC class II expression.
Main Results:
- Early influx of polymorphonuclear leukocytes and lymphocytes observed within 1-4 hours.
- Significant increase in lymphocyte lectin-mediated and natural killer cell cytotoxicity post-transplantation.
- MHC class II expression upregulated by 24 hours, with histologic signs of rejection by 1 week.
Conclusions:
- Ischemia-reperfusion injury alters the lung's local environment.
- This alteration enhances the allograft's susceptibility to acute rejection.
- Early immune activation plays a key role in initiating the rejection process.